Archive for October, 2013

Latest Articles from Journal of Pathology Informatics

| October 31, 2013 | 0 Comments

Diagnostic digital cytopathology: Are we ready yet? Jarret C House, Evita B Henderson-Jackson, Joseph O Johnson, Mark C Lloyd, Jasreman Dhillon, Nazeel Ahmad, Ardeshir Hakam, Walid E Khalbuss, Marino E Leon, David Chhieng, Xiaohui Zhang, Barbara A Centeno, Marilyn M Bui J Pathol Inform 2013, 4:28 (29 October 2013) [ABSTRACT]   [HTML FULL TEXT]   [PDF]   [Mobile HTML Full text ] […]

Continue Reading

Predicting Cancer Survival Using Multi-marker, Computer-Aided Method to Determine Phenotypes of Lymphocytes in Melanoma Tissue Sections

| October 31, 2013 | 0 Comments

The capacity of lymphocytes to infiltrate tumors is essential for T-lymphocyte-mediated tumor destruction and a high degree of tumor-infiltrating lymphocytes (TILs) is associated with a better prognosis. An understanding of the phenotype and spatial distribution of TILs within tumor regions would be valuable for characterizing host response. PerkinElmer’s novel multi-marker and counting approach using the […]

Continue Reading

Why Pathology?

| October 29, 2013 | 3 Comments

“What animates a great pathologist? Is it the desire to cure disease, to save life? Surely not, save perhaps as an afterthought. He is too intelligent, deep in his soul, to see anything praiseworthy in such a desire. He knows from life-long observation that his discoveries will do quite as much harm as good, that […]

Continue Reading

PathXL Launches TissueMark®

| October 24, 2013 | 0 Comments

TissueMark® is a ground-breaking, easy to use solution for the automated identification of tumor tissue on standard H&E stained digital slides. Request more information TissueMark® combines sophisticated algorithm technology with a straightforward, no nonsense workflow, supporting the pathologist with accurate and highly consistent tumor information and assisting the diagnostic process through optimization of tumor content […]

Continue Reading

DigiPath and Personalized Diagnostic Expand Digital Pathology into Chinese Market

| October 24, 2013 | 0 Comments

DigiPath, Inc. (OTCBB: DIGP) and Personalized Diagnostic, LLC, today announce they have entered in an agreement to expand DigiPath’s affordable, innovative, and reliable digital pathology solutions into the Chinese Market. Personalized Diagnostics, L.L.C. will focus on brokering strategic partnerships between DigiPath and Chinese biotech companies. With the expansion of digital pathology, patients will have access […]

Continue Reading

Digital Pathology Trends and Innovations

| October 22, 2013 | 0 Comments

Digital pathology is the work of taking the regular slides and tissue samples which would have gone under the microscope and scanning them into a digital image, which can be viewed on a computer screen for the very best understanding and analysis. This is a booming technology in medical lab work and several compelling trends […]

Continue Reading

Water Street Announces Sale of U.S. Anatomic Pathology Company to Miraca Life

| October 22, 2013 | 0 Comments

CHICAGO, Oct. 22, 2013 /PRNewswire/ — Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, announced today that it has sold its anatomic pathology company, PLUS Diagnostics (“PLUS”), to Miraca Life Sciences.  Water Street built PLUS into a national leader following its investment in the Irvine, Calif.-based company.  Its sale of PLUS to Miraca Life Sciences makes […]

Continue Reading

A Review of PathXL’s Experience of Pathology Visions 2013

| October 18, 2013 | 0 Comments

As Pathology Visions came to a close on 1st October and after a few manic days our team embarked on the dreaded task of packing up the booth and starting the journey back to the UK. Despite the physical tiredness from what was close to a week on the go our team returned back to […]

Continue Reading

Join PerkinElmer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston – October 19-23

| October 17, 2013 | 0 Comments

Visit our booth (#620) to learn about our full range of quantitative pathology solutions for imaging and quantifying biomarkers in tissue sections.  Stop by our poster on Tuesday, October 22nd on Phenotyping TILs in situ: Automated Enumeration of Tregs and Tacts in Solid Tumors which demonstrates the use of an automated method for counting Tregs […]

Continue Reading

Philips receives FDA clearance for Digital Manual Read of HER2 pathology slides

| October 17, 2013 | 0 Comments

Philips introduces clinical digital imaging product for pathologists. 510(k) clearance from the US Food and Drug Administration (FDA) allows Philips to market its Her2/neu IHC Digital Manual Read product in the US. Pathologists can now use a digital system from Philips to help them assess treatment options for breast cancer patients. Royal Philips (NYSE: PHG, […]

Continue Reading

Pathologists as Secret Weapons

| October 15, 2013 | 0 Comments

Not quite as popular (yet) as the

Continue Reading

Visiopharm and Omnyx Partner to Advance Cancer Diagnostics with Clinically Validated Image Analysis Algorithms for Pathologists

| October 15, 2013 | 0 Comments

Visiopharm a leader in Quantitative Digital Pathology and Omnyx LLC, a joint venture between GE Healthcare and UPMC a leader in digital pathology, partner to advance cancer diagnostics with clinically validated image analysis algorithms for pathologists.  Throughout the world there is a pressing need to improve and standardize the diagnostic work on cancer in order […]

Continue Reading

Obama reportedly open to repealing medical device tax

| October 15, 2013 | 0 Comments

Bloomberg News (10/12, Rowley, Tiron, Hunter) reported that Senate Republicans said President Obama “didn’t rule out” repealing a medical device tax in a Friday meeting with them on how to end the governing impasse. Sen. Orrin Hatch said, however, of the talks, “I came away with the feeling this is going to be a difficult […]

Continue Reading

Digital Pathology Improves TAT

| October 14, 2013 | 0 Comments

Digital Pathology is helping reduce wait times from biopsy to diagnosis and treatment. Instead of shipping glass slides to experts around the province, with digital pathology one of our specialized experts can look at the images no matter where they are in the province, country or the world. Together, expert pathologists can look at difficult […]

Continue Reading